PT-141 10mg

PT-141 10mg × 10 vials

A synthetic melanocortin peptide studied for melanocortin receptor research, sexual-function models, central nervous system signaling, arousal-related pathways, neuroendocrine mechanisms, and broader reproductive-behavior research protocols.

Product Overview

Compound: PT-141 / Bremelanotide
Strength: 10 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 10 mg
BAC water: 2 mL
Amount per unit: 50 mcg per unit

Research Dose

Protocol dependent.

Notes

PT-141, also known as Bremelanotide, is described as a synthetic peptide analogue derived from melanocortin research. It is studied primarily for its activity at melanocortin receptors, especially pathways connected with central nervous system signaling and sexual-response mechanisms.

Research literature has examined PT-141 in relation to sexual arousal models, libido-related pathways, neuroendocrine signaling, reproductive-behavior research, and melanocortin receptor activation.

Unlike compounds that act mainly through vascular mechanisms, PT-141 is generally discussed in research contexts as acting through central nervous system and melanocortin pathways.

Most available evidence includes laboratory, animal, and clinical research contexts. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.